Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,795,893
+$565,643 QoQ
Shares Held
168,517
+6.1% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#80
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. PCVX ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,795,893 | 168,517 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $9,230,250 | 158,841 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,963,402 | 150,919 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,599,296 | 183,212 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,452,812 | 198,487 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,843,244 | 181,230 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $14,064,694 | 171,814 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $18,752,049 | 164,103 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,028,365 | 159,295 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $10,129,963 | 148,294 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,198,602 | 130,551 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $6,643,203 | 130,310 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,201,499 | 124,179 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,567,121 | 95,174 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,401,666 | 91,797 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,637,520 | 68,230 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,339,284 | 61,548 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,226,554 | 50,789 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,116,631 | 46,937 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,204,390 | 47,473 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,020,738 | 45,346 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $564,514 | 28,583 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $595,088 | 22,397 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,007,401 | 20,401 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||